Table 1.
Subj. Nr. | Age | Sex [f = female, m = male] |
NLI | AIS grade | Etiology [1 = traumatic, 2 = non-traumatic] |
Time since injury [years] | Pain onset after injury [months] | Pain duration [years] | Pain intensity [NRS 0–10] | Presence of MSK | Presence of at-level NP | Pain medication |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | 52 | f | T10 | A | 1 | 23.4 | <6 | 23 | 3 | No | Yes | – |
2 | 55 | m | T1 | A | 1 | 11.8 | <12 | 11 | 3 | No | No | PGB |
3 | 35 | m | T11 | C | 1 | 14.5 | <6 | 14 | 4 | Yes | Yes | CB, PCM, MMZ |
4 | 53 | m | T5 | A | 1 | 20.4 | <6 | 20 | 3 | No | No | – |
5 | 75 | f | T10 | A | 2 | 14.4 | <1 | 15 | 7 | Yes | Yes | PGB, GPT |
6 | 59 | m | T9 | D | 1 | 6.7 | <1 | 7 | 1 | Yes | Yes | – |
7 | 58 | m | T11 | A | 2 | 24.1 | <1 | 24 | 6 | No | Yes | ATD, CBZ |
8 | 62 | m | T11 | C | 1 | 8.8 | <1 | 9 | 8 | Yes | Yes | ATD, PGB, CB |
9 | 36 | m | T11 | A | 1 | 6.7 | <1 | 7 | 6 | No | Yes | PGB, Voltaren |
10 | 75 | m | T10 | D | 2 | 13.8 | <1 | 14 | 7 | Yes | Yes | NA |
11 | 62 | m | T11 | A | 1 | 36.3 | <3 | 36 | 5 | Yes | Yes | – |
12 | 66 | m | T3 | D | 1 | 19.1 | <1 | 19 | 8 | No | No | – |
13 | 57 | m | T2 | A | 1 | 3.8 | <1 | 4 | 5 | Yes | Yes | ATD, PGB, CB |
14 | 61 | m | T8 | D | 2 | 11 | <1 | 11 | 5 | Yes | No | – |
15 | 63 | m | T12 | A | 1 | 16.8 | <2 | 17 | 3 | No | No | – |
16 | 62 | m | T1 | D | 1 | 36.4 | ~24 | 13 | 4 | No | No | – |
17 | 50 | m | T3 | D | 2 | 21.3 | <3 | 21 | 5.5 | No | No | – |
18 | 54 | m | T10 | C | 1 | 13.3 | <3 | 13 | 7 | Yes | Yes | PGB, PCM |
19 | 59 | m | T12 | C | 1 | 37.6 | >24 | 11 | 9 | Yes | No | – |
20 | 54 | f | T5 | D | 2 | 6.2 | <3 | 6 | 3 | No | No | AT, MMZ |
NLI neurological level of injury, AIS ASIA Impairment Scale, MSK musculoskeletal pain, NP neuropathic pain, PGB pregabalin, CB cannabinoids, PCM paracetamol, MMZ metamizol, GPT gabapentin, ATD antidepressants, AT amitriptyline.